In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
COVID-19 and Cardiology Read more

Pharmacotherapy in Older People - October 2020

Training course by the ESC Working Group on Cardiovascular Pharmacotherapy

16/10/2020 00:00 16/10/2020 00:00 Europe/Paris Pharmacotherapy in Older People - October 2020 ESC Working Group on Cardiovascular Pharmacotherapy contact@escardio.org true DD/MM/YYYY
Pharmacology and Pharmacotherapy
In-person
event

Summary

The European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy presents an engaging and interactive course to improve the professional knowledge and skills for cardiovascular pharmacotherapy in older patients.



Introduction

In Europe and the Western World in particular, the proportion of older persons is dramatically increasing, which is predicted to add tremendous extra pressure to the strained health care systems.

Cardiovascular drugs are among the most prevalent drugs administered to older people. In particular diuretics, antihypertensives, NOACs, antiarrhythmics, lipid lowering drugs and glucose lowering drugs. All these drug classes can lead to increased frailty and should in particular not be prescribed on a one-size-fits-all-basis to older people, and polypharmacy should be countered.

Our goal is for all participants to leave the meeting with the improved competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on services and patient outcomes.

Preliminary programme

The programme is subject to change.

GENERAL ASPECTS

Demographical developments and feasibility of treating older patients in a short stay unit- “The Elderly” trial

Drug metabolism in older people

DIURETICS

The problem of Hypo- and hyperkalemia in older people

ANTIHYPERTENSIVES

Anti-hypertensive treatment in older patients

ANTIARRHYTHMICS

Therapeutic decisions in the elderly

LIPID LOWERING DRUGS

Lipid lowering agent selection in the elderly

GLUCOSE LOWERING DRUGS

Tight glycemic control, pros and cons [Debate]

DOACS IN AF STROKE PREVENTION

The use of DOACs in older individuals

ANTIPLATELET THERAPY

Guidelines & beyond

POLYPHARMACY

Problems with polypharmacy in older people

 

Venue

The course will be held in Madrid, Spain.

Further details will be available in May.

Registration

Registration will open in May.

Registration fees

Registration fees are inclusive of applicable local VAT.

Category Fee (incl. VAT)
Working Group Members 120€
Working Group Members below 40 80€
Standard fee 300€

 

For any questions, please contact us on workinggroups@escardio.org

Become a member

This course is organised by the ESC Working Group on Cardiovascular Pharmacotherapy. Not member yet? Join today

Learning objectives

Reduction of cardiovascular disease burden by pharmacotherapy is a multistep approach, which requires:

  • the identification of new potential drugs;
  • testing new potential pharmacological compounds in trial setting;
  • regulatory approval;
  • implementation of therapies in clinical practice.

Older patients with cardiovascular disease are often shown to be undertreated. Among others, main reasons are polypharmacotherapy and thus fear for side effects, and sparse evidence from trials in this subgroup due to limited enrolment. Therefore, the older subgroup of patients with CV disease represents the ideal population who may benefit from strategies leading to implement the optimised use of pharmacotherapy.

The specific aim of this course is to improve competence and confidence to deliver better, personalized therapy of older people, which in turn will have a positive impact on implementing use of services and pharmacotherapy and thus patient outcomes.

Who should attend

POP courses are dedicated to physicians dealing with hospital admissions, ward and outpatient consultations 

Previous courses

The first course on Pharmacotherapy in Older People took place in October 2019 in London, with over 40 participants for the launch.

Access the resources

  • Over 90% of participants found the course extremely useful and useful to their daily practice
  • More than 80% rated the programme as 'excellent', with the speakers and topics as the most cited best aspects of the event
  • 95% of participants declared that the event fulfilled their educational goals and expected learning outcomes